Stock listing
Polyrizon Ltd.
Selected listing: PLRZ · NASDAQ · USD · US
Polyrizon Ltd. (NASDAQ:PLRZ), Health Technology. Latest release Oct 5, 2026: Polyrizon Files for U.S. Patent Application to Expand IP Moat Around Intranasal…
- Ticker
- NASDAQ:PLRZ
- Asset type
- Stock
- Sector
- Health Technology
- Industry
- Biotechnology
- Exchange
- NASDAQ
- Currency
- USD
About Polyrizon Ltd.
Polyrizon Ltd. is a public company traded under the ticker PLRZ in the American market. Polyrizon focuses on innovative solutions in its industry, contributing to advancements and developments in its field.
Latest news from Polyrizon Ltd.
Polyrizon Files for U.S. Patent Application to Expand IP Moat Around Intranasal Drug-Delivery Platform
October 5, 2026
Polyrizon Enrolls First Patient in U.S. Clinical Study of NASARIX (PL-14) Allergy Blocker
September 22, 2026
Polyrizon Ltd. Announces Closing of $4.0 Million Registered Direct Offering and Private Placement
September 4, 2026
Polyrizon Ltd. Announces $4.0 Million Registered Direct Offering and Private Placement
September 3, 2026
Polyrizon Completes All Five U.S. Site Contracts for NASARIX™ First-in-Human Allergy Study
September 2, 2026